Rnd3 Regulates Lung Cancer Cell Proliferation through Notch Signaling

Rnd3/RhoE is a small Rho GTPase involved in the regulation of different cell behaviors. Dysregulation of Rnd3 has been linked to tumorigenesis and metastasis. Lung cancers are the leading cause of cancer-related death in the West and around the world. The expression of Rnd3 and its ectopic role in non-small cell lung cancer (NSCLC) remain to be explored. Here, we reported that Rnd3 was down-regulated in three NSCLC cell lines: H358, H520 and A549. The down-regulation of Rnd3 led to hyper-activation of Rho Kinase and Notch signaling. The reintroduction of Rnd3 or selective inhibition of Notch signaling, but not Rho Kinase signaling, blocked the proliferation of H358 and H520 cells. Mechanistically, Notch intracellular domain (NICD) protein abundance in H358 cells was regulated by Rnd3-mediated NICD proteasome degradation. Rnd3 regulated H358 and H520 cell proliferation through a Notch1/NICD/Hes1 signaling axis independent of Rho Kinase.

[1]  T. Kobayashi,et al.  Pharmacological profile of hydroxy fasudil as a selective rho kinase inhibitor on ischemic brain damage. , 2001, Life sciences.

[2]  C. McGlade,et al.  Mammalian Numb Proteins Promote Notch1 Receptor Ubiquitination and Degradation of the Notch1 Intracellular Domain* , 2003, Journal of Biological Chemistry.

[3]  A. Gazdar,et al.  Oxygen concentration determines the biological effects of NOTCH-1 signaling in adenocarcinoma of the lung. , 2007, Cancer research.

[4]  E. Sahai,et al.  PDK1 regulates cancer cell motility by antagonising inhibition of ROCK1 by RhoE , 2008, Nature Cell Biology.

[5]  H. Friess,et al.  A pancreatic cancer-specific expression profile. , 1996, Oncogene.

[6]  G. V. van Muijen,et al.  Simultaneous suppression of progression marker genes in the highly malignant human melanoma cell line BLM after transfection with the adenovirus-5 E1A gene. , 1996, Biochemical and Biophysical Research Communications - BBRC.

[7]  Alexandre Pelzer,et al.  Small G‐protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosis , 2005, The Prostate.

[8]  Jiang Chang,et al.  Genetic deletion of Rnd3 results in aqueductal stenosis leading to hydrocephalus through up-regulation of Notch signaling , 2013, Proceedings of the National Academy of Sciences.

[9]  Francesco Favero,et al.  Reduced Expression of the ROCK Inhibitor Rnd3 Is Associated with Increased Invasiveness and Metastatic Potential in Mesenchymal Tumor Cells , 2010, PloS one.

[10]  G. Pelosi,et al.  Alterations of the Notch pathway in lung cancer , 2009, Proceedings of the National Academy of Sciences.

[11]  Tianli Fan,et al.  RhoE functions as a tumor suppressor in esophageal squamous cell carcinoma and modulates the PTEN/PI3K/Akt signaling pathway , 2012, Tumor Biology.

[12]  Y. Liu,et al.  [Expression and significance of Notch1, Jagged1 and VEGF in human non-small cell lung cancer]. , 2007, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.

[13]  I. Ng,et al.  RhoE is frequently down‐regulated in hepatocellular carcinoma (HCC) and suppresses HCC invasion through antagonizing the Rho/Rho‐Kinase/Myosin phosphatase target pathway , 2013, Hepatology.

[14]  E. Anton,et al.  Rnd-ing up RhoA activity to link neurogenesis with steps in neuronal migration. , 2011, Developmental Cell.

[15]  Donald M. Bell,et al.  Proneural Transcription Factors Regulate Different Steps of Cortical Neuron Migration through Rnd-Mediated Inhibition of RhoA Signaling , 2011, Neuron.

[16]  Sarah A. Boswell,et al.  RhoE Is a Pro-Survival p53 Target Gene that Inhibits ROCK I-Mediated Apoptosis in Response to Genotoxic Stress , 2016, Current Biology.

[17]  D. Fan,et al.  RhoE is Associated with Relapse and Prognosis of Patients with Colorectal Cancer , 2012, Annals of Surgical Oncology.

[18]  H. Akashi,et al.  Growth‐suppressive effect of non‐steroidal anti‐inflammatory drugs on 11 colon‐cancer cell lines and fluorescence differential display of genes whose expression is influenced by sulindac , 2000, International journal of cancer.

[19]  A. Aplin,et al.  FOXD3 Regulates Migration Properties and Rnd3 Expression in Melanoma Cells , 2011, Molecular Cancer Research.

[20]  Dinghua Yi,et al.  Notch signaling inhibits growth of the human lung adenocarcinoma cell line A549. , 2007, Oncology reports.

[21]  Sam W. Lee,et al.  Small GTPase RhoE/Rnd3 is a critical regulator of Notch1 signaling. , 2014, Cancer research.

[22]  Jie Huang,et al.  Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy. , 2014, Biochemical and biophysical research communications.

[23]  K. Mori,et al.  Socius Is a Novel Rnd GTPase-Interacting Protein Involved in Disassembly of Actin Stress Fibers , 2002, Molecular and Cellular Biology.

[24]  A. Ridley,et al.  RhoE Inhibits Cell Cycle Progression and Ras-Induced Transformation , 2004, Molecular and Cellular Biology.

[25]  Li-Xuan Qin,et al.  gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. , 2009, Cancer research.

[26]  Zhaoli Chen,et al.  Overexpression of RhoE Has a Prognostic Value in Non–Small Cell Lung Cancer , 2007, Annals of Surgical Oncology.

[27]  S. Grimwood,et al.  Determination of guinea-pig cortical gamma-secretase activity ex vivo following the systemic administration of a gamma-secretase inhibitor. , 2005, Neuropharmacology.

[28]  K. Hirschi,et al.  Hemogenic endothelial cell specification requires c-Kit, Notch signaling, and p27-mediated cell-cycle control. , 2013, Developmental cell.

[29]  Q. Zeng,et al.  Down‐regulation of RhoE is associated with progression and poor prognosis in hepatocellular carcinoma , 2012, Journal of surgical oncology.

[30]  Feng Bi,et al.  Suppression of RND3 activity by AES downregulation promotes cancer cell proliferation and invasion. , 2013, International journal of molecular medicine.

[31]  A. Takeshita,et al.  Suppression of Coronary Artery Spasm by the Rho-Kinase Inhibitor Fasudil in Patients With Vasospastic Angina , 2002, Circulation.

[32]  S. Grimwood,et al.  Determination of guinea-pig cortical γ-secretase activity ex vivo following the systemic administration of a γ-secretase inhibitor , 2005, Neuropharmacology.

[33]  A. Ridley,et al.  RhoE Binds to ROCK I and Inhibits Downstream Signaling , 2003, Molecular and Cellular Biology.

[34]  Kassem M. Makki,et al.  Rnd3/RhoE Is down‐regulated in hepatocellular carcinoma and controls cellular invasion , 2012, Hepatology.

[35]  J. George,et al.  Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer , 2014, Cell Death and Disease.

[36]  Zhaoli Chen,et al.  Overexpression of RhoE in non-small cell lung cancer (NSCLC) is associated with smoking and correlates with DNA copy number changes , 2007, Cancer biology & therapy.